Proinflammatory actions of angiotensins
Abstract
Many experimental data have suggested that the renin-angiotensin system participates in immune and inflammatory responses. Angiotensin II is involved in several steps of the inflammatory process: mononuclear cells respond to angiotensin II stimulation (cell proliferation and chemotaxis); angiotensin II regulates the recruitment of proinflammatory cells into the site of injury (mediated by the expression of vascular permeability factors, adhesion molecules and chemokines by resident cells); inflammatory cells can produce angiotensin II, and might therefore contribute to the perpetuation of tissue damage. In this review, we summarize the proinflammatory properties of angiotensin II, to demonstrate the novel role of this vasoactive peptide as a true cytokine. We will show the information obtained as a result of the pharmacological blockade of the renin angiotensin system, which has demonstrated that this system is involved in immune and inflammatory diseases. In this aspect, we discuss the molecular mechanism of angiotensin II-induced tissue damage, as well as its contribution to the pathogenesis of several diseases, including atherosclerosis, hypertension and renal damage, showing that angiotensin II plays an active role in the inflammatory response of these diseases.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
This leads to upregulation of complement pathways and TLR2, TLR3, and TLR4 leading to elevated IFNs and activation of the inflammasome resulting in amplified TNFα, IL-1β, and IL-6 to produce a cytokine storm.
“This leads to upregulation of complement pathways and TLR (Toll-like receptor) 2, TLR3, and TLR4 leading to elevated IFNs (interferons) and activation of the inflammasome resulting in amplified TNF α , IL-1 β , and IL-6 to produce a cytokine storm.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [62]
Cites
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212 · see citing works
Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647 · see citing works
Preactivated Peripheral Blood Monocytes in Patients With Essential Hypertension
Dörffel, Y., Lätsch, C., Stuhlmüller, B., Schreiber, S., Scholze, S., Burmester, G. R., & Scholze, J. (1999) · Hypertension · doi:10.1161/01.hyp.34.1.113 · Cited by 262 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
COVID-19 cytokine storm: the anger of inflammation
Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., & Nabipour, I. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155151 · Cited by 461 · see citing works
“Ang II can activate the nuclear factor kappa B (NF-κB) pathway [24,25] via stimulation of the phosphorylation of the p65 subunit of NF-κB [26].”
The metabolic syndrome: role of skeletal muscle metabolism.
Stump, C. S., Henriksen, E. J., Wei, Y., & Sowers, J. R. (2006) · Annals of Medicine · doi:10.1080/07853890600888413 · Cited by 362 · see citing works
Navarro, J. F., Mora, C., Macıéa, M., & Garcıéa, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00408-6 · Cited by 238 · see citing works
COVID-19, Myocarditis and Pericarditis
Fairweather, D., Beetler, D. J., Di Florio, D. N., Musigk, N., Heidecker, B., & Cooper, L. T. (2023) · Circulation Research · doi:10.1161/circresaha.123.321878 · Cited by 181 · see citing works
Zhao, J., Liu, J., Pang, X., Wang, S., Wu, D., Zhang, X., & Feng, L. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000354461 · Cited by 31 · see citing works
Devaux, C. A., & Camoin-Jau, L. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1042200 · Cited by 20 · see citing works
- Authors
- Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J.
- Affiliations
- Universidad Autónoma de Madrid (ES)
- Hospital Universitario Fundación Jiménez Díaz (ES)
- Corresponding author
- Egido, Jesús
- Venue
- Current Opinion in Nephrology and Hypertension
- Published
- 2001-05
- Volume
- 10
- Issue
- 3
- Pages
- 321-329
- ISSN
- 1062-4821 (ISSN-L)
- OpenAlex
- W2075604884
- Cited by
- 412
- References
- 3
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 11 · 2023: 11 · 2022: 22 · 2021: 23 · 2020: 13 · 2019: 9 · 2018: 8 · 2017: 15 · 2016: 8 · 2015: 13 · 2014: 16 · 2013: 23 · 2012: 17
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Nephrology & Hypertension (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Genetics › Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- angiotensin II, renin-angiotensin system, inflammation, immune response, cytokines, mononuclear cell proliferation, chemotaxis, vascular endothelial growth factor, adhesion molecules, chemokines, tissue damage, atherosclerosis, hypertension, kidney injury
- MeSH terms
- Angiotensin II, Animals, Humans, Inflammation, Renin-Angiotensin System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review